CD40 and cancer: Similarly, autologous whole cancer cell vaccines composed of irradiated cancer cells pulsed with TLR agonists and anti-CD40 were shown to induce a strong anticancer immunity and prolonged survival of tumor-bearing mice in a way dependent on T cells [100].